Ethan is an experienced deal lawyer who helps guide clients through strategic transactions of all sizes, often involving cutting-edge technologies, including artificial intelligence, augmented reality, digital therapeutics and gene therapy.

Ethan advises clients on M&A transactions on both the buy-side and the sell-side, drawing on years of experience leading deals in the technology and life sciences industries.

Ethan also acts as an outside advisor to technology and life sciences companies on corporate governance and other matters, and regularly represents venture capital and private equity investors in technology and life sciences investments.

  • Representative Technology/Media Transactions
    • ThousandEyes in its acquisition by Cisco
    • Seal Software in its acquisition by DocuSign
    • DocuSign in its acquisition of LiveOak
    • Billie in its sale to P&G
    • eSilicon in the divestiture of certain assets to Synopsys and sale to Inphi
    • SignalFX in its $1.05B sale to Splunk
    • Peloton in multiple acquisition transactions
    • GF Capital Management in multiple acquisition transactions
    • Segovia in its acquisition by Crown Agents Bank
    • Mphasis in its acquisition of Stelligent Systems
    • Lendup in the restructuring of its credit card business
    • Jama Software in its recapitalization by Insight Venture Partners
    • Mimosa Networks in its acquisition by Airspan Networks
    • Grovo Learning in its acquisition by Cornerstone OnDemand
    • Delphi in its acquisition of nuTonomy
    • Gigya in its acquisition by SAP
    • Bonobos in its acquisition by Walmart
    • The principal investor in the acquisition of Blue Man Group by Cirque du Soleil
    • Bitly in its acquisition by Spectrum Equity
    • Steelwedge in its acquisition by E2Open
    • Zen Planner in its acquisition by Daxko
    • 160/90 in its acquisition by Searchlight Capital
    • Funding Circle in its acquisition of Endurance Lending Networks
    • Behance in its acquisition by Adobe Systems
    • Buddy Media in its $800M acquisition by, and in Buddy Media’s acquisitions of Spinback and Brighter Option
    • SNL Financial in its leveraged recapitalization by New Mountain Capital
  • Representative Life Sciences Transactions
    • ZipDrug in its acquisition by Anthem Health
    • Chinook Therapeutics in its pending merger with Aduro Biotech
    • Mavupharma in its acquisition by Abbvie
    • Propeller Health in its acquisition by ResMed
    • Corium International in its acquisition by Gurnet Point Capital
    • Celenex in its acquisition by Amicus Therapeutics
    • Channel Medsystems in its merger agreement with Boston Scientific
    • Covis Pharma and Covis Injectables in their all-cash $1.2B sale of assets to Concordia Healthcare
    • G&W Laboratories in its acquisition of Teva Pharmaceuticals’ manufacturing plant and portfolio of pharmaceutical products
    • Cerberus Capital Management in its $105M control investment in PaxVax
    • Caladrius in its acquisition of California Stem Cell
    • Covis Pharma in its acquisitions of pharmaceutical products from Sanofi and Bayer AG
    • Cerberus Capital Management in its investment in Covis Pharma
    • Princeton Pharma Holdings and its wholly owned subsidiary Aton Pharma in their $318M acquisition by Valeant Pharmaceuticals
    • Celldex Therapeutics in its $93.5M acquisition of CuraGen, and in its $129M stock-for-stock merger with Avant Immunotherapeutics
    • Vital Signs in its $870M cash merger with GE Healthcare
    • LifeCell in its $1.7B two-step tender offer/merger with Kinetic Concepts
    • GF Capital Private Equity Fund in its acquisition of the assets of Airborne Health
    • Tamir Biotechnology in its sale to Orgenesis​
    • Merck in the combination of its ILÚM Health Solutions business with UPMC's Infectious Disease Connect
  • Representative Other Transactions
    • The Estée Lauder Companies in its $1.4B acquisition of Too Faced Cosmetics and its acquisitions of Le Labo and Applied Genetics Incorporated Dermatics
    • Indorama Ventures, in its acquisitions of CEPSA Chimie Montreal, the U.S. and Mexican polyester and PET resins business of Invista and FiberVisions from Snow Phipps Group
    • Cytec Industries in the $105M acquisition of its pressure-sensitive adhesives business by Henkel

Education & Admissions

J.D., Columbia University School of Law
Stone Scholar

B.A., cum laude, English literature
Middlebury College

Admitted to practice in New York and New Jersey


Don’t have an account yet?